A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge

The recent worldwide incidence of mpox infection and concerns about future emerging variants of mpox viruses highlight the need for the development of a new generation of mpox vaccines. To achieve this goal, we utilized our norovirus S nanoparticle vaccine platform to produce and evaluate two pseudo...

Descripción completa

Detalles Bibliográficos

Autores principales:	Pengwei Huang, Ming Xia, Frank S. Vago, Wen Jiang, Ming Tan
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2024-07-01
Colección:	Vaccines
Materias:	mpox vaccinia smallpox vaccine norovirus S particle pseudovirus nanoparticle
Acceso en línea:	https://www.mdpi.com/2076-393X/12/8/846
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!